Literature DB >> 21315763

Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates.

Hsuen-Wen Chang1, Chia-Chyi Liu, Min-Han Lin, Hui-Min Ho, Ya-Ting Yang, Yen-Hung Chow, Pele Chong, Charles Sia.   

Abstract

A live enterovirus 71 (EV71) isolate designated, EV71/E59, with genotype B4 produced in Vero cells and purified over a sucrose gradient was used as the immunogen to generate EV71-specific murine monoclonal antibodies. Four hybridoma clones derived from the fusion of splenocytes of EV71/E59-preimmunized BALB/c (H-2(d)) mice and the NS-1 myeloma cells that exhibit stable growth were selected for detailed characterization. The proof that the hybridomas produced are indeed true independent clones was based on the obervations that they expressed different complementarity-determining regions (CDRs) in their κ light chain genes. Purified ascitic fluids produced by the individual clones reacted against the viral capsid protein, VP1, in Western blot; and recognized distinct sites of a common epitope localized at the C-terminal half of VP1. Each of the monoclonal antibodies exhibited potent neutralizing activities against the immunizing virus strain, as well as two other isolates namely, N0781-TW-01, and N2838, of subgenogroups B4 and B5, respectively, that were found commonly in recent outbreaks in Taiwan. It was also observed the monoclonal antibodies acted cooperatively in neutralizing the EV71/E59 virus.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315763     DOI: 10.1016/j.jviromet.2011.02.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles.

Authors:  Tao Lin; Lingzhi Xianyu; Songya Lyu
Journal:  Virol Sin       Date:  2015-05-29       Impact factor: 4.327

2.  The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro.

Authors:  Kristin L Shingler; Javier O Cifuente; Robert E Ashley; Alexander M Makhov; James F Conway; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

3.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

4.  Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.

Authors:  Tanja K Kiener; Qiang Jia; Xiao Fang Lim; Fang He; Tao Meng; Vincent Tak Kwong Chow; Jimmy Kwang
Journal:  Virol J       Date:  2012-02-24       Impact factor: 4.099

5.  Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Cheng-Peng Chang; Meng-Shin Guo; Shih-Yang Hsieh; Wen-Hsueh Yang; Hsin-Ju Chao; Chien-Long Wu; Ju-Lan Huang; Min-Shi Lee; Alan Yung-Chi Hu; Sue-Chen Lin; Yu-Yun Huang; Mei-Hua Hu; Yen-Hung Chow; Jen-Ron Chiang; Jui-Yuan Chang; Pele Chong
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

6.  Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.

Authors:  Yueh-Liang Tsou; Yi-Wen Lin; Hsiao-Yun Shao; Shu-Ling Yu; Shang-Rung Wu; Hsiao-Yu Lin; Chia-Chyi Liu; Chieh Huang; Pele Chong; Yen-Hung Chow
Journal:  PLoS Negl Trop Dis       Date:  2015-04-09

7.  Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.

Authors:  Kam Leng Aw-Yong; I-Ching Sam; Mia Tuang Koh; Yoke Fun Chan
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

8.  Immunological and biochemical characterization of coxsackie virus A16 viral particles.

Authors:  Pele Chong; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Shu-Yang Weng; Ai-Hsiang Chou; Jen-Ren Wang; Shih-Yang Hsieh; Ih-Jen Su; Chia-Chyi Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.

Authors:  Hsuen-Wen Chang; Yi-Wen Lin; Hui-Min Ho; Min-Han Lin; Chia-Chyi Liu; Hsiao-Yun Shao; Pele Chong; Charles Sia; Yen-Hung Chow
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

10.  Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Jui-Yuan Chang; Renee Jiang; Yi-Chin Hsieh; Amanda Tsao; Chien-Long Wu; Ju-Lan Huang; Chang-Phone Fung; Szu-Min Hsieh; Ya-Fang Wang; Jen-Ren Wang; Mei-Hua Hu; Jen-Ron Chiang; Ih-Jen Su; Pele Choi-Sing Chong
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.